Article in Cancer prevention research (Philadelphia, Pa.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors.
Kevin E Goggin *Department of Microbiology and Immunology, School of Medicine, University of Louisville, Louisville, Kentucky.ORCID 0009-0005-4541-464X
SeonYeong Jamie Seo *Department of Microbiology and Immunology, School of Medicine, University of Louisville, Louisville, Kentucky.ORCID 0009-0000-0910-0081
Benjamin G WuDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, New York.ORCID 0000-0001-8547-5678
Sinisa IveljaDepartment of Pathology, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, New York.ORCID 0009-0002-4947-8753
Matthias C KuglerDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, New York.ORCID 0000-0002-8587-6129
Miao ChangDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, New York.ORCID 0000-0003-0300-4499
Fares DarawshyDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, New York.ORCID 0000-0003-0177-908X
Yonghua LiDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, New York.ORCID 0009-0009-1988-9640
Cecilia J ChungDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, New York.ORCID 0000-0003-2392-1745
Yaa KyerematengDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, New York.ORCID 0009-0001-6004-1301
Jun-Chieh J TsayDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, New York.ORCID 0000-0002-2282-2510
Shivani SinghDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, New York.ORCID 0009-0007-1337-6161
Daniel H StermanDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, New York.ORCID 0009-0004-0170-2722
Leopoldo N SegalDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, New York.ORCID 0000-0003-3559-9431
Nejat K EgilmezDepartment of Microbiology and Immunology, School of Medicine, University of Louisville, Louisville, Kentucky.ORCID 0000-0002-2544-2767
Qingsheng LiDepartment of Microbiology and Immunology, School of Medicine, University of Louisville, Louisville, Kentucky.ORCID 0000-0001-5350-258X
Funding
The role of ECM-mediated mechanosignaling on regional immunosuppression in GBMP20GM135004 · NIGMS · UNIVERSITY OF LOUISVILLE · PI Sharmila Nair · 2020 to 2026
$21.1M
Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancerU2CCA271890 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Leopoldo Nicolas Segal · 2023 to 2026
$4.7M
Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancerR37CA244775 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Leopoldo Nicolas Segal · 2020 to 2026
$4.7M
Age related loss of immune resilience during response to severe respiratory viral infectionsU01AG088351 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHRISTIAN FORST, Leopoldo Nicolas Segal · 2024 to 2026
$1.5M
BIOREPOSITORY OPTIMIZATION AND USE FOR ENDOTYPING CRITICALLY ILL SARS-COV-2 INFECTED PATIENTSR21GM147800 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SEGAL, LEOPOLDO NICOLAS · 2022 to 2023
$460k
BLRD VA IK2 BX005309Defense Health Agency (DHA) LC220290National Institute of General Medical Sciences (NIGMS) P20-GM135004National Institute of General Medical Sciences (NIGMS) R21GM147800NCI NIH HHS R37 CA244775NCI NIH HHS U2C CA271890NIA NIH HHS U01 AG088351NIGMS NIH HHS P20 GM135004NIGMS NIH HHS R21 GM147800U.S. Department of Veterans Affairs (VA) IK2BX005309-01A2
6 · The paper itself
Abstract
The role of dietary fiber in colon cancer prevention remains controversial. We investigated its impact on antitumor immunity and the gut microbiota in APCmin/+ mice infected with enterotoxigenic Bacteroides fragilis. Mice were fed high-fiber, low-fiber, or chow diets, and the tumor burden, survival, cytokines, microbiota, and metabolites were analyzed. Contrary to the belief that high fiber inhibits tumor progression, it had no significant impact compared with chow diet. However, the low-fiber diet significantly reduced the tumor burden and improved survival. Mechanistically, high fiber increased proinflammatory cytokines and CD4+Foxp3+RORγt+IL-17A+ regulatory T cells, whereas low fiber enhanced anti-inflammatory cytokines and cytotoxic T cells. High fiber enriched microbial taxa associated with IL-17A+RORγt+ regulatory T cells and altered metabolites, including reduced tryptophan and increased short-chain fatty acids and bile acids. Low fiber produced opposite effects. These findings suggest that dietary fiber's effects on colon cancer depends on microbial infection and immune status, emphasizing the need for personalized dietary interventions in colon cancer management. Prevention Relevance: Dietary fiber's impact on colon cancer progression highlights the need for personalized dietary approaches, considering microbial infection and immune status.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Differential Effects of High-Fiber and Low-Fiber Diets on Antitumor Immunity and Colon Tumor Progression in a Murine Model. · full record | OpenQuestion